ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Change in Estimated Glomerular Filtration Rate and Risk of Allograft Failure in Patients Diagnosed with Active Antibody-Mediated Rejection Following Kidney Transplantation

W. Irish1, P. Nickerson2, B. Astor3, E. Chong4, C. Wiebe2, F. Moreso5, D. Seron5, M. Crespo5, L. Gache6, A. Djamali3

1East Carolina University, Greenville, NC, 2University of Manitoba, Winnipeg, MB, Canada, 3University of Wisconsin, Madison, WI, 4Vitaeris, Inc, Vancouver, BC, Canada, 5University Hospital Vall d'Hebron, Barcelona, Spain, 6CTI Clinical Trial & Consulting, Covington, KY

Meeting: 2019 American Transplant Congress

Abstract number: A197

Keywords: Graft survival, Multivariate analysis, Prediction models, Renal function

Session Information

Date: Saturday, June 1, 2019

Session Name: Poster Session A: Kidney Chronic Antibody Mediated Rejection

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Hall C & D

Related Abstracts
  • The Combination of Area under Curve of Estimated Glomerular Filtration Rate for 2 Years and Annual Rate Change of Estimated Glomerular Filtration Rate Predicts Long-Term Graft Survival in Kidney Transplants
  • Change in Estimated Glomerular Filtration Rate Pre and Post Development of Donor-Specific Antibodies after Kidney Transplantation

*Purpose: There are challenges in designing an adequate and well-controlled study of patients with active antibody-mediated rejection (ABMR), especially in the absence of a valid surrogate marker. The objective of this study was to evaluate the functional relationship between change in estimated GFR (eGFR) following diagnosis of active ABMR and risk of death-censored graft failure (DCGF), defined as graft loss or eGFR < 15 mL/min/1.73 m2 occurring at any time over the course of patient follow up.

*Methods: Recipients of solitary KTx between January 1995 and August 2013 who were diagnosed with biopsy-proven ABMR at least one-year post-KTx and had a minimum of 3 years follow-up. Serial measures of eGFR were calculated using the MDRD 4-variable equation. The relationship between change in eGFR and risk of DCGF was assessed using the joint modelling (JM) framework. Within the JM framework, two models are fit to the data simultaneously: one for the longitudinal process (change in eGFR) and one for the event process (time to DCGF). Joint estimation of the two models is achieved by assuming they are correlated via individual random effects.

*Results: A total of 91 patients across three participating centers were included in the analysis: 9 (10%) from Barcelona, 27 (30%) from Manitoba, and 55 (60%) from Wisconsin. The mean (SD) age of the recipient at time of KTx was 39.4 (15.1) years, 27.5% were female and 86.8% were white. Median length of time from KTx to diagnosis of active ABMR was 63 months. Median follow-up post-diagnosis of active ABMR was 62 months. Spaghetti plots suggest a linear trend in the change in eGFR; especially in the first 12 months post-diagnosis of active ABMR. Results of the joint model are presented in Table 1. Baseline eGFR and slope (per month change in eGFR up to 12 months post-diagnosis of active ABMR) are associated with risk of DCGF: for each mL increase in baseline eGFR or improvement in mL/month of eGFR slope, risk of DCGF is significantly reduced.

*Conclusions: This study provides important insight into the utility of pivotal trial endpoints and can be used for sample size estimation given a set of assumptions based on the anticipated eGFR profile.

Table 1: Results of the Joint Model
A. Linear Mixed Effects (random intercept-slope) Model for the Longitudinal eGFR Process
Comparison Estimate Standard Error P-value
Intercept 50.884 7.869 <0.0001
Time (slope)  Per month -0.757 0.104 <0.0001
B. Cox’s Hazards Model for Time to Death-censored Graft Failure
Comparison Estimate (Log hazard ratio) Standard Error P-value
Estimated GFR at time of diagnosis Per unit increase -0.128 0.030 <0.0001
Slope Per month increase in eGFR -2.233 0.580 <0.0001
  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Irish W, Nickerson P, Astor B, Chong E, Wiebe C, Moreso F, Seron D, Crespo M, Gache L, Djamali A. Change in Estimated Glomerular Filtration Rate and Risk of Allograft Failure in Patients Diagnosed with Active Antibody-Mediated Rejection Following Kidney Transplantation [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/change-in-estimated-glomerular-filtration-rate-and-risk-of-allograft-failure-in-patients-diagnosed-with-active-antibody-mediated-rejection-following-kidney-transplantation/. Accessed March 8, 2021.

« Back to 2019 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Home
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Search
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Home
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.